Répertoire du corps professoral

2SHARP:Two Fractions Study of Hypofractionated Ablative Radiotherapy for Prostate Cancer.
Organisme(s) subventionnaire(s): AbbVie Corporation
Type de financement: Subvention
Établissement tête: Université Laval
Du 19 juin 2024 au 31 mars 2025

A Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN)
Organisme(s) subventionnaire(s): NRG Oncology
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 avril 2022 au 28 février 2025

The impact of Monte Carlo dose calculations on prostate and breast low-dose rate brachytherapy dose-outcome relationships and radiobiological modeling
Programme: Subvention Projet
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 octobre 2020 au 30 septembre 2025

Encadrements terminés dans les 5 dernières années

Marc Gaudet, Maîtrise en épidémiologie - épidémiologie clinique - avec mémoire

Publications des 5 dernières années

Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials Radiotherapy and Oncology, 2024/06. Abdenour Nabid, Nathalie Carrier, Eric Vigneault, André-Guy Martin, Jean-Paul Bahary, Thu Van Nguyen, Peter Vavassis, Sylvie Vass, Marc-André Brassard, Boris Bahoric, Robert Archambault, François Vincent, Redouane Bettahar, Marie Duclos, Derek Wilke, Luis Souhami. DOI 10.1016/j.radonc.2024.110256

Image-Guided Brachytherapy for Rectal Cancer: Reviewing the Past Two Decades of Clinical Investigation Cancers, 2022/10/04. Te Vuong, Aurelie Garant, Veronique Vendrely, Remi Nout, André-Guy Martin, Shirin A. Enger, Ervin Podgorsak, Belal Moftah, Slobodan Devic. DOI 10.3390/cancers14194846

MORPHEUS Phase II–III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results Cancers, 2022/07. Aurelie Garant, Carol-Ann Vasilevsky, Marylise Boutros, Farzin Khosrow-Khavar, Petr Kavan, Hugo Diec, Sylvain Des Groseilliers, Julio Faria, Emery Ferland, Vincent Pelsser, Andre-Guy Martin, Slobodan Devic, Te Vuong. DOI 10.3390/cancers14153665

Inter-observer evaluation of a GPU-based multicriteria optimization algorithm combined with plan navigation tools for HDR brachytherapy Brachytherapy, 2022/07. Cédric Bélanger, Éric Poulin, Sylviane Aubin, Éric Vigneault, André-Guy Martin, William Foster, Luc Beaulieu. DOI 10.1016/j.brachy.2022.04.003

PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study Brachytherapy, 2021/11. Thomas Reynaud, Lara Hathout, Damien Carignan, Maroie Barkati, André-Guy Martin, William Foster, Frédéric Lacroix, Guila Delouya, Daniel Taussky, Gerard Morton, Eric Vigneault. DOI 10.1016/j.brachy.2021.05.010